LONDON (ShareCast) - (Sharecast News) - Oesophageal Doppler monitoring firm Deltex Medical Group saw its shares dip on Wednesday after the company revealed that, although its 2017 pre-tax loss had narrowed, the company's revenues declined 6% to £5.9m.
The company attributed the revenue decline to a £500,000 decline from UK probe sales, while international sales also fell, by 5% to £1.9m, but offset by 5% growth in US revenues to £2m.

Despite this, the company managed to pare its pre-tax loss by 16%.

Management said it achieved savings by bringing probe production in house and putting new manufacturing processes in place, resulting in a £400,000 reduction in its operating losses.

Nigel Keen, chairman of Deltex Medical, said: "The progress made towards operating cash breakeven and profitability through improved consumable margins and reduced overheads made during 2017 was partially offset by a disappointing second half sales performance."

In the meantime, Deltex Medical also announced the launch of the TrueVue Loops display software on its CardioQ-ODM+ haemodynamic monitoring platform.

The AIM-traded company said the software will allow users to view a simultaneous display of a patient's aortic blood flow velocity, taken directly from the TrueVue Doppler probe, and aortic blood pressure, from a continuous blood pressure device.

Ewan Phillips, chief executive of Deltex Medical, said: "By giving doctors, for the first time ever, a complete and continuous picture of a patient's central haemodynamic status the Loops should take the science of haemodynamics forward in both intensive and peri-operative care. The initial focus on vaso-active drugs offers the possibility of Deltex building a strong competitive advantage in this area to match its existing strength in fluid management."

Doctors from Paris' Lariboisiere Hospital developed the software with a focus on using TrueVueTM Loops to identify the effects of administering vaso-active drugs and to guide their safe administration.

As of 1247 BST, Deltex Medical Group's shares were down 7.14% at 1.30p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE